Variant Bio

Genomic Drug Discovery

Variant Bio is leveraging cutting-edge genomics and computational biology to discover and develop novel therapeutics for rare diseases. Their unique approach leverages the power of genomics to identify individuals with exceptional health traits and uncover the underlying genetic mechanisms responsible for these traits. Combining various types of biological data to identify causal genes and establish disease mechanisms. Their proprietary, VB-Inference platform, uses advanced analytics to infer causal relationships from complex genetic data. Variant Bio's reliance on multi-omic data and advanced analytics provides a robust foundation for drug discovery. Variant Bio has a pipeline of drug candidates targeting various diseases, including rare genetic disorders and neurodegenerative conditions.